These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 34120859)

  • 1. Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis.
    Navarro P; Laserna-Mendieta EJ; Guagnozzi D; Casabona S; Perelló A; Savarino E; de la Riva S; Olalla JM; Ghisa M; Serrano-Moya N; Alcolea-Valero C; Ortega-Rabbione G; Majano P; Santander C; Arias Á; Lucendo AJ;
    Dig Liver Dis; 2021 Nov; 53(11):1479-1485. PubMed ID: 34120859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinant factors for first-line treatment choice and effectiveness in pediatric eosinophilic esophagitis: an analysis of the EUREOS EoE CONNECT registry.
    Navarro P; Feo-Ortega S; Casabona-Francés S; Gutiérrez-Junquera C; Savarino EV; Amorena E; Fernández-Fernández S; Pérez-Martínez I; Oliva S; Barrio J; Masiques-Mas ML; Guardiola-Arévalo A; Guagnozzi D; Racca F; Betoré E; Votto M; Rodríguez-Sánchez A; Barrio ML; Blas-Jhon L; Sánchez-Vegazo CT; García-Morales N; Krarup AL; Dainese R; Martín-Dominguez V; García-Díaz A; Maniero D; Santander C; Arias Á; Laserna-Mendieta EJ; Lucendo AJ
    Eur J Pediatr; 2024 Aug; 183(8):3567-3578. PubMed ID: 38819501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry.
    Laserna-Mendieta EJ; Casabona S; Guagnozzi D; Savarino E; Perelló A; Guardiola-Arévalo A; Barrio J; Pérez-Martínez I; Lund Krarup A; Alcedo J; de la Riva S; Rey-Iborra E; Santander C; Arias Á; Lucendo AJ;
    Aliment Pharmacol Ther; 2020 Sep; 52(5):798-807. PubMed ID: 32677040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults.
    Molina-Infante J; Ferrando-Lamana L; Ripoll C; Hernandez-Alonso M; Mateos JM; Fernandez-Bermejo M; Dueñas C; Fernandez-Gonzalez N; Quintana EM; Gonzalez-Nuñez MA
    Clin Gastroenterol Hepatol; 2011 Feb; 9(2):110-7. PubMed ID: 20920599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACCURACY OF THE EOSINOPHILIC ESOPHAGITIS ENDOSCOPIC REFERENCE SCORE IN CHILDREN.
    Ribeiro LM; Vieira MC; Truppel SK; Rosário Filho NA
    Arq Gastroenterol; 2024; 61():e23103. PubMed ID: 38451662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis.
    Andreae DA; Hanna MG; Magid MS; Malerba S; Andreae MH; Bagiella E; Chehade M
    Am J Gastroenterol; 2016 Aug; 111(8):1187-97. PubMed ID: 27325220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study.
    Dellon ES; Speck O; Woodward K; Gebhart JH; Madanick RD; Levinson S; Fritchie KJ; Woosley JT; Shaheen NJ
    Am J Gastroenterol; 2013 Dec; 108(12):1854-60. PubMed ID: 24145677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis.
    van Rhijn BD; Weijenborg PW; Verheij J; van den Bergh Weerman MA; Verseijden C; van den Wijngaard RM; de Jonge WJ; Smout AJ; Bredenoord AJ
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1815-23.e2. PubMed ID: 24657840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proton Pump Inhibitor-responsive Esophageal Eosinophilia: An Overview of Cases from One University Hospital Center].
    Ahn B; Lee DH; Lee CM; Hwang JJ; Yoon H; Shin CM; Park YS; Kim N
    Korean J Gastroenterol; 2016 Apr; 67(4):178-82. PubMed ID: 27112243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients.
    Jiao D; Ishimura N; Maruyama R; Ishikawa N; Nagase M; Oshima N; Aimi M; Okimoto E; Mikami H; Izumi D; Okada M; Ishihara S; Kinoshita Y
    J Gastroenterol; 2017 Feb; 52(2):203-210. PubMed ID: 27108416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis-Results from the population-based DanEoE cohort shows a low complication rate.
    Frandsen LT; Westmark S; Melgaard D; Krarup AL
    United European Gastroenterol J; 2021 Oct; 9(8):910-918. PubMed ID: 34477326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophil-Derived Neurotoxin Predicts Response to Proton-Pump Inhibitor Treatment in Pediatric Eosinophilic Esophagitis.
    Irastorza LE; Hopson P; Nabar S; Deb C; Smadi Y
    J Pediatr Gastroenterol Nutr; 2022 Feb; 74(2):267-271. PubMed ID: 34321427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophilic esophagitis in Japan: Focus on response to acid suppressive therapy.
    Ishimura N; Kinoshita Y
    J Gastroenterol Hepatol; 2018 May; 33(5):1016-1022. PubMed ID: 29278655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal Biopsy Protocol to Evaluate Histological Effectiveness of Proton Pump Inhibitor Therapy in Patients with Eosinophilic Esophagitis.
    Fujiwara Y; Hashimoto A; Uemura R; Sawada A; Otani K; Tanaka F; Yamagami H; Tanigawa T; Watanabe T; Kabata D; Kuwae Y; Shintani A; Ohsawa M
    Digestion; 2019; 100(1):64-71. PubMed ID: 30408792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor.
    Vazquez-Elizondo G; Ngamruengphong S; Khrisna M; Devault KR; Talley NJ; Achem SR
    Aliment Pharmacol Ther; 2013 Nov; 38(10):1312-9. PubMed ID: 24117619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservative long-term treatment of children with eosinophilic esophagitis.
    Levine J; Lai J; Edelman M; Schuval SJ
    Ann Allergy Asthma Immunol; 2012 May; 108(5):363-6. PubMed ID: 22541409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of proton pump inhibitor therapy in the management of eosinophilic esophagitis.
    Molina-Infante J; Prados-Manzano R; Gonzalez-Cordero PL
    Expert Rev Clin Immunol; 2016 Sep; 12(9):945-52. PubMed ID: 27097787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids.
    Rajan J; Newbury RO; Anilkumar A; Dohil R; Broide DH; Aceves SS
    J Allergy Clin Immunol; 2016 Jan; 137(1):147-156.e8. PubMed ID: 26233926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitor-responsive esophageal eosinophilia: still a valid diagnosis?
    Molina-Infante J; Gonzalez-Cordero PL; Lucendo AJ
    Curr Opin Gastroenterol; 2017 Jul; 33(4):285-292. PubMed ID: 28445189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings.
    Moawad FJ; Schoepfer AM; Safroneeva E; Ally MR; Chen YJ; Maydonovitch CL; Wong RK
    Aliment Pharmacol Ther; 2014 Mar; 39(6):603-8. PubMed ID: 24461332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.